Related Experiment Video
Updated: Sep 28, 2026

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
Simvastatin-nelfinavir interaction implicated in rhabdomyolysis and death
C Bradley Hare1, Mai P Vu, Carl Grunfeld
1Division of Infectious Diseases, University of California, San Francisco, California 94110, USA. chare@php.ucsf.edu
Abstract:
We report the first death associated with rhabdomyolysis in a patient treated with a statin and a protease inhibitor, which produced a significant drug-drug interaction.
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Pharmacokinetics: Drug–Food and Drug–Viral Interactions
Drug toxicity: Drug–Drug Interaction
Inhibitors of Viral Protein Synthesis
Pharmacokinetics: Drug–Drug Interactions
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

